This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent. Top assignees: Takeda Chemical Industries, Inc., Other. Active years: 2001-2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2001-2003
Title: **Fritz Schueckler: Innovator in the Field of D-Mannitol**
Introduction
Fritz Schueckler is an accomplished inventor based in Leverkusen, Germany. He has made significant contributions to the field of pharmaceutical excipients, particularly through his innovative work on D-mannitol. With two patents to his name, Schueckler's research has paved the way for advancements in medicinal formulations.
Latest Patents
One of Schueckler's notable patents focuses on D-mannitol and its preparation. The patent describes D-mannitol with a specific surface area of not less than about 1 m²/g, which exhibits improved compressibility. This innovation makes D-mannitol especially useful as an excipient in various pharmaceutical applications. His dedication to improving the physical properties of this compound has opened doors for more effective medicinal formulations.
Career Highlights
Throughout his career, Schueckler has worked with notable companies, including Takeda Chemical Industries, Inc. This experience has allowed him to apply his inventive skills in a collaborative environment, further enhancing his expertise in pharmaceutical sciences.
Collaborations
Schueckler has collaborated with esteemed colleagues such as Tomohiro Yoshinari and Norbert Poellinger. Their collective efforts have contributed to the development and refinement of innovative formulations in the pharmaceutical industry.
Conclusion
Fritz Schueckler's inventive spirit has significantly impacted the field of medicinal excipients, particularly through his advancements in D-mannitol. His patents not only showcase his innovative ability but also demonstrate his commitment to enhancing the quality of pharmaceutical products. As he continues to work alongside talented colleagues, the future of pharmaceutical innovations looks promising with his contributions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile